seed
Stage
2
Investors
About
Protai develops an AI-driven platform combining structural proteomics and machine learning to identify and model protein complexes, facilitating target identification and accelerating small-molecule drug discovery focused on immunology and oncology.
Explore Protai's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.